Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue -, Pages 16105
Publisher
Springer Nature
Online
2017-07-25
DOI
10.1038/ncomms16105
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype
- (2015) Natassia M. Vieira et al. CELL
- Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
- (2015) J. W. McGreevy et al. Disease Models & Mechanisms
- High-Pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline
- (2015) Zheng Fan et al. HUMAN GENE THERAPY
- Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus
- (2015) Yongping Yue et al. HUMAN MOLECULAR GENETICS
- Intra-Amniotic rAAV-Mediated Microdystrophin Gene Transfer Improves Canine X-Linked Muscular Dystrophy and May Induce Immune Tolerance
- (2015) Hiromi Hayashita-Kinoh et al. MOLECULAR THERAPY
- The potential of adeno-associated viral vectors for gene delivery to muscle tissue
- (2014) Dan Wang et al. Expert Opinion on Drug Delivery
- Elimination of contaminating cap genes in AAV vector virions reduces immune responses and improves transgene expression in a canine gene therapy model
- (2014) Z Wang et al. GENE THERAPY
- Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients
- (2014) Caroline Le Guiner et al. MOLECULAR THERAPY
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy
- (2014) Thibaut Larcher et al. PLoS One
- Microdystrophin Ameliorates Muscular Dystrophy in the Canine Model of Duchenne Muscular Dystrophy
- (2013) Jin-Hong Shin et al. MOLECULAR THERAPY
- Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
- (2013) LG Chicoine et al. MOLECULAR THERAPY
- Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
- (2012) Joe N. Kornegay et al. MAMMALIAN GENOME
- Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping
- (2012) Adeline Vulin et al. MOLECULAR THERAPY
- Successful Regional Delivery and Long-term Expression of a Dystrophin Gene in Canine Muscular Dystrophy: A Preclinical Model for Human Therapies
- (2012) Zejing Wang et al. MOLECULAR THERAPY
- Comprehensive longitudinal characterization of canine muscular dystrophy by serial NMR imaging of GRMD dogs
- (2012) J.-L. Thibaud et al. NEUROMUSCULAR DISORDERS
- Splitting of Pi and other 31P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy
- (2012) Claire Wary et al. NMR IN BIOMEDICINE
- Systemic Delivery of Allogenic Muscle Stem Cells Induces Long-Term Muscle Repair and Clinical Efficacy in Duchenne Muscular Dystrophy Dogs
- (2011) Karl Rouger et al. AMERICAN JOURNAL OF PATHOLOGY
- Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs
- (2011) Inès Barthélémy et al. BMC MUSCULOSKELETAL DISORDERS
- Delivery of AAV2/9-Microdystrophin Genes Incorporating Helix 1 of the Coiled-Coil Motif in the C-Terminal Domain of Dystrophin Improves Muscle Pathology and Restores the Level of α1-Syntrophin and α-Dystrobrevin in Skeletal Muscles of mdx Mice
- (2011) Taeyoung Koo et al. HUMAN GENE THERAPY
- A Simplified Immune Suppression Scheme Leads to Persistent Micro-dystrophin Expression in Duchenne Muscular Dystrophy Dogs
- (2011) Jin-Hong Shin et al. HUMAN GENE THERAPY
- Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog
- (2011) Taeyoung Koo et al. JOURNAL OF GENE MEDICINE
- Safety and Feasibility of High-pressure Transvenous Limb Perfusion With 0.9% Saline in Human Muscular Dystrophy
- (2011) Zheng Fan et al. MOLECULAR THERAPY
- Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B
- (2010) V. R. Arruda et al. BLOOD
- Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production
- (2010) C L Halbert et al. GENE THERAPY
- Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs
- (2010) Virginia Haurigot et al. MOLECULAR THERAPY
- Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs
- (2010) Joe N Kornegay et al. MOLECULAR THERAPY
- Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials
- (2010) Virginia Arechavala-Gomeza et al. NEUROMUSCULAR DISORDERS
- Duchenne muscular dystrophy: Survival by cardio-respiratory interventions
- (2010) Yuka Ishikawa et al. NEUROMUSCULAR DISORDERS
- Lack of Immunotoxicity After Regional Intravenous (RI) Delivery of rAAV to Nonhuman Primate Skeletal Muscle
- (2009) Alice Toromanoff et al. MOLECULAR THERAPY
- Gait analysis using accelerometry in dystrophin-deficient dogs
- (2009) Inès Barthélémy et al. NEUROMUSCULAR DISORDERS
- Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle
- (2008) Alice Toromanoff et al. MOLECULAR THERAPY
- Codon and mRNA Sequence Optimization of Microdystrophin Transgenes Improves Expression and Physiological Outcome in Dystrophic mdx Mice Following AAV2/8 Gene Transfer
- (2008) Helen Foster et al. MOLECULAR THERAPY
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
- Sarcolemma-localized nNOS is required to maintain activity after mild exercise
- (2008) Yvonne M. Kobayashi et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started